🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

eHealth appoints Prama Bhatt to its board of directors

Published 09/24/2024, 04:17 PM
EHTH
-

AUSTIN, Texas - eHealth, Inc. (NASDAQ:EHTH), an online marketplace for health insurance, announced today the appointment of Prama Bhatt as a new independent member of its Board of Directors. Bhatt's tenure as a Class II director begins immediately and will extend until the company's Annual Meeting of Stockholders in 2026.

Bhatt, with a notable background in digital transformation and consumer growth strategies, will also serve on the Audit Committee and the Government and Regulatory Affairs Committee of the Board. Her expertise is expected to bolster eHealth's ongoing efforts to enhance its digital platform and expand its business operations.

Fran Soistman, CEO of eHealth, expressed confidence in Bhatt's alignment with the company's strategic priorities, citing her successful track record in driving digital transformation. Similarly, Board Chairperson Beth Brooke highlighted Bhatt's deep expertise in digital transformation and strategic leadership as key assets for the company's future growth and innovation.

With a rich career history, Bhatt has held executive roles at Ulta Beauty (NASDAQ:ULTA), Inc., Kenneth Cole Productions, Inc., and Toys "R" Us, Inc., contributing to their digital and e-commerce initiatives. She also currently serves on the boards of Hormel Foods Corporation (NYSE:HRL) and JD (NASDAQ:JD) Sports Fashion PLC.

Upon her appointment, Bhatt expressed her honor in joining eHealth's Board and her eagerness to collaborate with the leadership team to support the company's growth and develop solutions that empower informed health insurance decisions for beneficiaries.

eHealth, celebrating over 25 years in service, provides access to a broad range of health insurers and has been instrumental in helping millions of Americans find suitable healthcare coverage. The company prides itself on being a matchmaker between consumers and health insurance plans, offering products from a wide array of national and regional insurers.

This announcement is based on a press release statement from eHealth, Inc.


In other recent news, eHealth Inc. reported its Q2 2024 results, with the total revenue slightly declining by 1.4% year-over-year to $65.9 million. This, however, surpassed both the consensus forecast of $55.0 million and Deutsche Bank's estimate of $52.8 million. The revenue growth was primarily driven by a 6.9% year-over-year increase in Medicare revenue, reaching $59.2 million, and a 16% rise in total Medicare submissions.

On the other hand, Deutsche Bank revised its price target for eHealth, lowering it to $2.00 from the previous $5.00, while maintaining a Hold rating on the company's stock. This adjustment followed the recent earnings release and was influenced by the company's financial performance, including an adjusted EBITDA loss of $15.5 million, notably better than the anticipated loss of $24.3 million by analysts and the $22.1 million loss previously estimated by Deutsche Bank.

Among other recent developments, eHealth's CEO, Fran Soistman, announced his retirement plans, set to occur by or before Q2 2025. John Dolan was named as the successor to the current CFO, John Stelben, effective August 31. The company is targeting positive free cash flow by March 2025 and has raised its revenue guidance for Fiscal Year 2024 to between $470 million and $495 million. These developments reflect the company's ongoing strategic efforts and leadership transitions.


InvestingPro Insights


As eHealth, Inc. (NASDAQ:EHTH) welcomes Prama Bhatt to its Board of Directors, the company's financial health and market performance remain a focal point for investors. With an emphasis on digital transformation and growth, the InvestingPro data and tips provide a snapshot of the company's current financial landscape.

eHealth's market capitalization stands at $117.47 million, reflecting its size and value in the market as of the last twelve months ending Q2 2024. Despite facing challenges, as indicated by a negative Price/Earnings (P/E) ratio of -1.58, the company shows a robust gross profit margin of 99.62%, suggesting effective cost control in generating revenue.

InvestingPro Tips reveal that eHealth is expected to see net income growth this year, which could signal a turnaround from previous performance woes. The company is also trading at a low Price/Book multiple of 0.21, potentially indicating that the stock is undervalued relative to its assets. This could be an attractive point for investors seeking opportunities in companies with solid asset bases relative to their market prices.

However, it is important to note that eHealth has not been profitable over the last twelve months, and the stock has experienced significant price volatility. The company's stock price has notably declined by 29.46% over the last six months, which could be a concern for investors looking for stable returns.

For those interested in a deeper dive into eHealth's financials and stock performance, InvestingPro offers additional insights. There are currently 10 more InvestingPro Tips available at https://www.investing.com/pro/EHTH, providing a more comprehensive understanding of the company's potential and investment profile.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.